joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive spinal surgery in conjunction with the Korean Wooridul group, reported to be the world’s largest specialized spine hospital network. Since 2004, >600 spine surgeons and specialists from 41 countries have participated in courses at Wooridul.
joimax systems for endoscopic minimally invasive spinal surgery include TESSYS® transforaminal, iLESSYS® interlaminar and CESSYS® cervical for decompression procedures, MultiZYTE® SI for SI joint therapy or with EndoLIF® and Percusys® for endoscopic minimally-invasive assisted stabilization. For 2016, the company announced sales growth of +31% vs. 2015.
joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive...
joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive spinal surgery in conjunction with the Korean Wooridul group, reported to be the world’s largest specialized spine hospital network. Since 2004, >600 spine surgeons and specialists from 41 countries have participated in courses at Wooridul.
joimax systems for endoscopic minimally invasive spinal surgery include TESSYS® transforaminal, iLESSYS® interlaminar and CESSYS® cervical for decompression procedures, MultiZYTE® SI for SI joint therapy or with EndoLIF® and Percusys® for endoscopic minimally-invasive assisted stabilization. For 2016, the company announced sales growth of +31% vs. 2015.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
